【researchmap】
https://researchmap.jp/nagakura_yukinori

＜総説＞
Nagakura Y. Therapeutic approaches to nociplastic pain based on findings in the reserpine-induced fibromyalgia-like animal model. J Pharmacol Exp Ther 381:106-119, 2022.
Nagakura Y. Nagaoka S, Kurose T. Potential molecular targets for treating neuropathic orofacial pain based on current findings in animal models. Int J Mol Sci 22: 6406, 2021.
Nagakura Y. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics. Drug Dev Res 79:147-156, 2018.
Nagakura Y. The need for fundamental reforms in the pain research field to develop innovative drugs. Expert Opin Drug Discov 12:39-46, 2017.
Nagakura Y. Challenges in drug discovery for overcoming ‘dysfunctional pain’: an emerging category of chronic pain. Expert Opin Drug Discov 10:1043-1045, 2015.
＜原著論文＞
Nagakura Y, Kato H, Asano S, Jinno Y, Tanei S. The significant association between health examination results and population health: A cross-sectional ecological study using a nation-wide health checkup database in Japan. Int J Environ Res Public Health: 18:836, 2021.
Tanei S, Chu WT, Okamura T, Chen FS, Nagakura Y. Country and gender differences in the color association with energy drinks: A survey in Taiwanese and Japanese students. Foods: 9:1670, 2020.
Tanei S, Miwa M, Yoshida M, Miura R, Nagakura Y. The method simulating spontaneous pain in patients with nociplastic pain using rats with fibromyalgia-like condition. MethodsX 7: 100826, 2020.
Nagakura Y, Miwa M, Yoshida M, Miura R, Tanei S, Tsuji M, Takeda H. Spontaneous pain-associated facial expression and efficacy of clinically used drugs in the reserpine-induced rat model of fibromyalgia. Eur J Pharmacol 864:172716, 2019.
Uchida M, Kobayashi O, Yoshida M, Miwa M, Miura R, Saito H, Nagakura Y. Coexistence of alterations of gastrointestinal function and mechanical allodynia in the reserpine-induced animal model of fibromyalgia. Dig Dis Sci 64:2538-2547, 2019.
Nagakura Y, Ohsaka N, Azuma R, Takahashi S, Takebayashi Y, Kawasaki S, Murai S, Miwa M, Saito H. Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice. Physiol Behav 190: 505-514, 2018.